Objective:This study investigated the regulatory effect of non-classical immune parameters on immune thrombocytopenic purpura(ITP)mice by a spleen-invigorating,qi-replenishing and blood-containing formula(SQBF).Method...Objective:This study investigated the regulatory effect of non-classical immune parameters on immune thrombocytopenic purpura(ITP)mice by a spleen-invigorating,qi-replenishing and blood-containing formula(SQBF).Method:A total of 80 BALB/c mice were randomly divided into four equal groups(20 mice each):control group,model group,prednisone group and spleen-invigorating,qi-replenishing and blood-containing(SQBF)group.Mice in the model group,prednisone group,and SQBF group were administered anti-platelet serum to induce ITP.The dynamic variations of platelet counts in ITP mice were measured with an automatic blood analyzer before modeling and 48 h,and 8,12 and 15 days following APS injection.Levels of b-endorphin(b-EP),vasoactive intestinal peptide(VIP)and salivary IgA(SIgA)were detected by enzyme-linked immunosorbent assay(ELISA)on 15th day of experiment.Results:SQBF enhanced peripheral blood platelet counts in ITP mice similar to that of prednisone,and both groups showed a statistically significant response compared with the model group(P<.01).The SQBF significantly decreased b-EP levels compared with the model and prednisone intervention groups(P<.05),significantly increased the levels of VIP and SIgA in ITP mice compared with the model group(P<.05)and had significant protective effects on the thymus of ITP mice compared with the model group(P<.01).Conclusions:The SQBF had a similar effect to prednisone with regards to enhancing peripheral blood platelet counts in ITP mice.Furthermore,it decreased b-EP levels and increased VIP and SIgA,and protected the thymus.This shows that,on base of the brain-gut axis functions,some non-classical immune vascular active factors or neurotransmitters are also involved in immune responses,and also have relationship with the onset of ITP and bleeding and/or hemostasis.It needs further study to determine whether a change in these active factors is related to immediate hemostasis.展开更多
Objective:Finding an effective therapy against Alzheimer’s disease(AD)has been associate increasingly pressing issue and traditional Chinese medicine(TCM)is widespread in the prevention and treatment of AD in China.T...Objective:Finding an effective therapy against Alzheimer’s disease(AD)has been associate increasingly pressing issue and traditional Chinese medicine(TCM)is widespread in the prevention and treatment of AD in China.The aim of this study was to judge the efficaciousness and safety of TCM kidney-nourishing(the changes of pathological state of kidney deficiency by means of TCM treatment and so on)formula(TKNF)for AD in comparison with donepezil.Methods:The retrieval period of seven databases was from the establishment of each database to April 2019.Two authors independently identified randomized controlled trials(RCTs),fetched data and assessed bias risk.Comprehensive analysis process was conducted with review manager for eligible and appropriate RCTs.Results:A complete of 981 AD patients from 13 studies were enclosed.Meta-analysis of RCTs showed that there was no significant difference in the improvement of Alzheimer's disease assessment scale-cognitive subscale score between 2 groups in short term,but the effect of long-term treatment may exceed donepezil;there was a significant difference in the improvement of activities of daily living score between 2 groups;there was a significant difference in TCM curative efficacy between 2 groups with long-term treatment.There was no significant difference in the incidence of adverse events between 2 groups.The quality of the evidence was high or moderate.Conclusion:Compared with donepezil,TKNF was an effective drug for AD patients and the clinical application of TKNF was safe.TKNF's long-term benefits need more evidence to verify.展开更多
To observe the after-effect duration of kidney-nourishing and marrow-replenishing therapy on Mediterranean anemia. Methods: To observe the kidney-nourishing and marrow-replenishing therapy on 58 cases of Mediterranea...To observe the after-effect duration of kidney-nourishing and marrow-replenishing therapy on Mediterranean anemia. Methods: To observe the kidney-nourishing and marrow-replenishing therapy on 58 cases of Mediterranean anemia and the influence of various relative factors on the after-effect duration. Results: The after-effect duration on 58 cases varied from 3-6 months, about 4 months on average, and was not influenced by sex, clinical types, genetic types, types of Mediterranean anemia and other factors. Conclusion: Kidney-nourishing and marrow-replenishing therapy used to treat Mediterranean anemia can not only produce good therapeutic effect during treatment but also keep after effect lasting for about 4 months, indicating that the therapy used to treat Mediterranean anemia has good clinical after effect.展开更多
Objective:This article uses a meta-analysis system to evaluate the clinical efficacy of the method of spleen-invigorating,kidney-tonifying and blood-activating combined with western medicine in the treatment of diabet...Objective:This article uses a meta-analysis system to evaluate the clinical efficacy of the method of spleen-invigorating,kidney-tonifying and blood-activating combined with western medicine in the treatment of diabetic nephropathy,in order to provide evidence-based medicine for the clinical treatment of this disease.Methods:Computer search(January 2009 to June 2020)published in CNKI,Wanfang database,and Weipu Chinese Science and Technology Journal Database with simple western medicine conventional treatment(control group)and on the basis of control group Randomized Controlled Trial(RCT)of the treatment of diabetic nephropathy with spleen-invigorating,kidney-tonifying and blood-activating(experimental group),and manual retrieval of relevant literature that meets the inclusion criteria.Two researchers independently carried out literature screening,and used the improved Jadad rating scale for quality evaluation,and finally used RevMan5.3 statistical software for meta-analysis.Results:A total of 15 randomized controlled trials were included,with a total of 1218 patients,including 621 in the experimental group and 597 in the control group.Meta-analysis showed that the experimental group was improving clinical efficacy(OR=4.35,95%CI[3.12,6.08],P<0.00001),FPG(MD=-0.49,95%CI[-0.89,-0.09],P=0.02),24h urine protein quantification(MD=-0.54,95%CI[-0.90,-0.18],P=0.003),mALB(MD=-15.95,95%CI[-18.12,-13.79],P<0.0001),BUN(MD=-1.79,95%CI[-2.99,-0.59],P=0.004),SCr(MD=-47.63,95%CI[-83.43,-11.83],P=0.009),TC(MD=-1.02,95%CI[-1.42,-0.62],P<0.00001),etc.may be better than the control group;The test group is improving TG(MD=-1.02,95%CI[-1.42,-0.62],P<0.00001)there is no significant difference compared with the control group.Conclusion:The method of spleen-invigorating,kidney-tonifying and blood-activating combined with conventional western medicine treatment of diabetic nephropathy may be superior to conventional western medicine treatment in terms of improving clinical efficacy,FPG,24h urine protein quantification,mALB,BUN,SCr,TC,etc.However,due to the small number and low quality of the literature included in this study,more in-depth research needs to further expand the sample size and include higher quality RCTs.展开更多
Blood-arresting Formula on simvastatin-induced zebrafish hemorrhage model compared with that of the Heat-clearing and Blood-cooling Formula.Methods:AB strain wild type zebrafish were treated with 0.5 mM simvastatin fo...Blood-arresting Formula on simvastatin-induced zebrafish hemorrhage model compared with that of the Heat-clearing and Blood-cooling Formula.Methods:AB strain wild type zebrafish were treated with 0.5 mM simvastatin for 24 hours to establish the zebrafish hemorrhage model.Under strictly blind experimental conditions,the zebrafish were then treated with experimental agents in different concentration within the maximum non-lethal dose.The intervention effect of the Spleen-invigorating,Qi-replenishing and Blood-arresting Formula was comprehensively assessed by examining the main observational parameters such as the bleeding reduction rate and hemostatic rate while referring to the additional parameters such as blood flow,improvement rate of blood flow,velocity of movement,improvement rate of motion under spleen-qi deficiency.Results:Hemostatic effect:The bleeding rate and hemostatic rate in the zebrafish were respectively,30%,15%,45%,40%and 60%,80%,40%,47%when equal concentration of 500 mg/mL,1000 mg/mL were used.This showed that the experimental herbs B1 was superior to B2 in decreasing the bleeding rate and improving hemostatic effect in the zebrafish.Improvement of blood flow:With equal concentration,the experimental herb B1 was superior to B2 in increasing the blood flow and improvement rate of blood flow in hemorrhagic zebrafish.Promotion of the improvement of motion:With equal concentration of 500 mg/mL and 1000 mg/mL,the experimental herb B1 was superior to B2 in promoting the velocity of motion in the zebrafish and promoting the improvement rate of motion.Conclusion:The manifestations of simvastatin-induced zebrafish hemorrhage are basically similar to that of failure of the spleen to control blood in human beings.The Spleeninvigorating,Qi-replenishing and Blood-arresting Formula has good hemostatic effect on simvastatin-induced hemorrhage in the zebrafish.It also boasts the functions of improving blood flow and velocity of motion in the hemorrhagic zebrafish.Such a conclusion provides the experimental basis for the treatment of the syndrome of failure of the spleen to control blood by this formula.展开更多
文摘Objective:This study investigated the regulatory effect of non-classical immune parameters on immune thrombocytopenic purpura(ITP)mice by a spleen-invigorating,qi-replenishing and blood-containing formula(SQBF).Method:A total of 80 BALB/c mice were randomly divided into four equal groups(20 mice each):control group,model group,prednisone group and spleen-invigorating,qi-replenishing and blood-containing(SQBF)group.Mice in the model group,prednisone group,and SQBF group were administered anti-platelet serum to induce ITP.The dynamic variations of platelet counts in ITP mice were measured with an automatic blood analyzer before modeling and 48 h,and 8,12 and 15 days following APS injection.Levels of b-endorphin(b-EP),vasoactive intestinal peptide(VIP)and salivary IgA(SIgA)were detected by enzyme-linked immunosorbent assay(ELISA)on 15th day of experiment.Results:SQBF enhanced peripheral blood platelet counts in ITP mice similar to that of prednisone,and both groups showed a statistically significant response compared with the model group(P<.01).The SQBF significantly decreased b-EP levels compared with the model and prednisone intervention groups(P<.05),significantly increased the levels of VIP and SIgA in ITP mice compared with the model group(P<.05)and had significant protective effects on the thymus of ITP mice compared with the model group(P<.01).Conclusions:The SQBF had a similar effect to prednisone with regards to enhancing peripheral blood platelet counts in ITP mice.Furthermore,it decreased b-EP levels and increased VIP and SIgA,and protected the thymus.This shows that,on base of the brain-gut axis functions,some non-classical immune vascular active factors or neurotransmitters are also involved in immune responses,and also have relationship with the onset of ITP and bleeding and/or hemostasis.It needs further study to determine whether a change in these active factors is related to immediate hemostasis.
基金National Natural Science Foundation of China(No.81573865).
文摘Objective:Finding an effective therapy against Alzheimer’s disease(AD)has been associate increasingly pressing issue and traditional Chinese medicine(TCM)is widespread in the prevention and treatment of AD in China.The aim of this study was to judge the efficaciousness and safety of TCM kidney-nourishing(the changes of pathological state of kidney deficiency by means of TCM treatment and so on)formula(TKNF)for AD in comparison with donepezil.Methods:The retrieval period of seven databases was from the establishment of each database to April 2019.Two authors independently identified randomized controlled trials(RCTs),fetched data and assessed bias risk.Comprehensive analysis process was conducted with review manager for eligible and appropriate RCTs.Results:A complete of 981 AD patients from 13 studies were enclosed.Meta-analysis of RCTs showed that there was no significant difference in the improvement of Alzheimer's disease assessment scale-cognitive subscale score between 2 groups in short term,but the effect of long-term treatment may exceed donepezil;there was a significant difference in the improvement of activities of daily living score between 2 groups;there was a significant difference in TCM curative efficacy between 2 groups with long-term treatment.There was no significant difference in the incidence of adverse events between 2 groups.The quality of the evidence was high or moderate.Conclusion:Compared with donepezil,TKNF was an effective drug for AD patients and the clinical application of TKNF was safe.TKNF's long-term benefits need more evidence to verify.
文摘To observe the after-effect duration of kidney-nourishing and marrow-replenishing therapy on Mediterranean anemia. Methods: To observe the kidney-nourishing and marrow-replenishing therapy on 58 cases of Mediterranean anemia and the influence of various relative factors on the after-effect duration. Results: The after-effect duration on 58 cases varied from 3-6 months, about 4 months on average, and was not influenced by sex, clinical types, genetic types, types of Mediterranean anemia and other factors. Conclusion: Kidney-nourishing and marrow-replenishing therapy used to treat Mediterranean anemia can not only produce good therapeutic effect during treatment but also keep after effect lasting for about 4 months, indicating that the therapy used to treat Mediterranean anemia has good clinical after effect.
基金The second round of construction project of the National Traditional Chinese Medicine School Inheritance Studio of the State Administration of Traditional Chinese Medicine(Guo TCM Ren Jiao Han[2019]No.62)Scientific Research Project of the Shaanxi Provincial Administration of Traditional Chinese Medicine(No.2019-ZZ-LC006)Shaanxi The construction project of famous traditional Chinese medicine inheritance studio of Provincial Administration of Traditional Chinese Medicine(No.2019017).
文摘Objective:This article uses a meta-analysis system to evaluate the clinical efficacy of the method of spleen-invigorating,kidney-tonifying and blood-activating combined with western medicine in the treatment of diabetic nephropathy,in order to provide evidence-based medicine for the clinical treatment of this disease.Methods:Computer search(January 2009 to June 2020)published in CNKI,Wanfang database,and Weipu Chinese Science and Technology Journal Database with simple western medicine conventional treatment(control group)and on the basis of control group Randomized Controlled Trial(RCT)of the treatment of diabetic nephropathy with spleen-invigorating,kidney-tonifying and blood-activating(experimental group),and manual retrieval of relevant literature that meets the inclusion criteria.Two researchers independently carried out literature screening,and used the improved Jadad rating scale for quality evaluation,and finally used RevMan5.3 statistical software for meta-analysis.Results:A total of 15 randomized controlled trials were included,with a total of 1218 patients,including 621 in the experimental group and 597 in the control group.Meta-analysis showed that the experimental group was improving clinical efficacy(OR=4.35,95%CI[3.12,6.08],P<0.00001),FPG(MD=-0.49,95%CI[-0.89,-0.09],P=0.02),24h urine protein quantification(MD=-0.54,95%CI[-0.90,-0.18],P=0.003),mALB(MD=-15.95,95%CI[-18.12,-13.79],P<0.0001),BUN(MD=-1.79,95%CI[-2.99,-0.59],P=0.004),SCr(MD=-47.63,95%CI[-83.43,-11.83],P=0.009),TC(MD=-1.02,95%CI[-1.42,-0.62],P<0.00001),etc.may be better than the control group;The test group is improving TG(MD=-1.02,95%CI[-1.42,-0.62],P<0.00001)there is no significant difference compared with the control group.Conclusion:The method of spleen-invigorating,kidney-tonifying and blood-activating combined with conventional western medicine treatment of diabetic nephropathy may be superior to conventional western medicine treatment in terms of improving clinical efficacy,FPG,24h urine protein quantification,mALB,BUN,SCr,TC,etc.However,due to the small number and low quality of the literature included in this study,more in-depth research needs to further expand the sample size and include higher quality RCTs.
基金National Key Basic Research and Development Program(973 Program)(2013CB531705).
文摘Blood-arresting Formula on simvastatin-induced zebrafish hemorrhage model compared with that of the Heat-clearing and Blood-cooling Formula.Methods:AB strain wild type zebrafish were treated with 0.5 mM simvastatin for 24 hours to establish the zebrafish hemorrhage model.Under strictly blind experimental conditions,the zebrafish were then treated with experimental agents in different concentration within the maximum non-lethal dose.The intervention effect of the Spleen-invigorating,Qi-replenishing and Blood-arresting Formula was comprehensively assessed by examining the main observational parameters such as the bleeding reduction rate and hemostatic rate while referring to the additional parameters such as blood flow,improvement rate of blood flow,velocity of movement,improvement rate of motion under spleen-qi deficiency.Results:Hemostatic effect:The bleeding rate and hemostatic rate in the zebrafish were respectively,30%,15%,45%,40%and 60%,80%,40%,47%when equal concentration of 500 mg/mL,1000 mg/mL were used.This showed that the experimental herbs B1 was superior to B2 in decreasing the bleeding rate and improving hemostatic effect in the zebrafish.Improvement of blood flow:With equal concentration,the experimental herb B1 was superior to B2 in increasing the blood flow and improvement rate of blood flow in hemorrhagic zebrafish.Promotion of the improvement of motion:With equal concentration of 500 mg/mL and 1000 mg/mL,the experimental herb B1 was superior to B2 in promoting the velocity of motion in the zebrafish and promoting the improvement rate of motion.Conclusion:The manifestations of simvastatin-induced zebrafish hemorrhage are basically similar to that of failure of the spleen to control blood in human beings.The Spleeninvigorating,Qi-replenishing and Blood-arresting Formula has good hemostatic effect on simvastatin-induced hemorrhage in the zebrafish.It also boasts the functions of improving blood flow and velocity of motion in the hemorrhagic zebrafish.Such a conclusion provides the experimental basis for the treatment of the syndrome of failure of the spleen to control blood by this formula.